DCF — ENCOMPASS HEALTH REHABILITATION HOSP
Enterprise Value: $-16.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-16.5M
Enterprise Value
$-5.6M
PV of Cash Flows
$-10.9M
PV of Terminal Value
$-17.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $22.6M | $-0.8M | -4.0% | $-1.8M | $-1.6M |
| Year 2 | $23.3M | $-0.6M | -3.0% | $-1.6M | $-1.3M |
| Year 3 | $24.0M | $-0.4M | -2.0% | $-1.4M | $-1.0M |
| Year 4 | $24.7M | $-0.3M | -1.0% | $-1.3M | $-0.9M |
| Year 5 | $25.4M | $-0.2M | -1.0% | $-1.3M | $-0.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-16.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$21.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.040573218940920995
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5